Paraoxonase 1 Gene Polymorphisms Do Not Influence the Response to Treatment in Alzheimer's Disease

被引：11
|
作者：
Klimkowicz-Mrowiec, A. [1 ]
Marona, M. [3 ]
Spisak, K. [3 ]
Jagiella, J. [3 ]
Wolkow, P. [2 ]
Szczudlik, A. [1 ]
Slowik, A. [1 ]
机构：
[1] Jagiellonian Univ, Dept Neurol, PL-31503 Krakow, Poland
[2] Jagiellonian Univ, Dept Pharmacol, PL-31503 Krakow, Poland
[3] Univ Hosp, Dept Neurol, Krakow, Poland
来源：
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS | 2011年 / 32卷 / 01期
关键词：
Acetylcholinesterase inhibitors; Alzheimer's disease; Paraoxonases; Polymorphisms; Response to treatment; DONEPEZIL; ACETYLCHOLINESTERASE;
D O I：
10.1159/000330343
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Background: Acetylcholinesterase inhibitors (AChEIs) are the treatment of choice for patients with Alzheimer's disease (AD). However, their efficacy is moderate and differs from patient to patient. Recent studies suggest that the Q192R variant of the paraoxonase 1 gene (PON1) might affect individual susceptibility to these drugs. Methods: We investigated the influence of 3 single nucleotide polymorphisms (SNPs) in PON1 (rs 662, rs 854560, rs 705381) and the APOE common polymorphism in 101 Polish patients with late-onset AD in response to treatment with AChEIs. Results: No significant differences were observed between carriers and non-carriers of the PON1 SNPs or the APOE common polymorphism in terms of treatment response. These results did not change after stratification of APOE status. Conclusion: Our results suggest that both the investigated PON1 and APOE common SNPs do not influence treatment response to AChEIs in patients with AD. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码：26 / 31
页数：6
相关论文
共 50 条
  • [31] Paraoxonase 1 gene polymorphisms and dementia in humans
    Helbecque, N
    Cottel, D
    Codron, V
    Berr, C
    Amouyel, P
    [J]. NEUROSCIENCE LETTERS, 2004, 358 (01) : 41 - 44
  • [32] Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease
    Kelada, SN
    Costa-Mallen, P
    Checkoway, H
    Viernes, HA
    Farin, FM
    Smith-Weller, T
    Franklin, GM
    Costa, LG
    Checkoway, H
    Longstreth, WT
    Furlong, CE
    Jarvik, GP
    Furlong, CE
    Jarvik, GP
    Longstreth, WT
    Swanson, PD
    Costa, LG
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (04): : 546 - 547
  • [33] Influence of polymorphisms in interleukin-1 gene on amyloid and non-amyloid vascular pathologies in Alzheimer's disease
    Tian, J
    Shi, J
    Mann, DM
    Lendon, C
    Green, E
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 138B (01) : 42 - 42
  • [34] Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology
    Leduc, Valerie
    Theroux, Louise
    Dea, Doris
    Robitaille, Yves
    Poirier, Judes
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2009, 30 (09) : 1823 - 1830
  • [35] No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese population
    Wang, J
    Liu, ZL
    [J]. MOVEMENT DISORDERS, 2000, 15 (06) : 1265 - 1267
  • [36] BDNF Gene Polymorphisms are Associated with Alzheimer's Disease-Related Depression and Antidepressant Response
    Zhang, Lu
    Fang, Yu
    Zeng, Zhaoshu
    Lian, Yajun
    Wei, Jianke
    Zhu, Hongcan
    Jia, Yanjie
    Zhao, Xinyu
    Xu, Yuming
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 (03) : 523 - 530
  • [37] Polymorphisms in the promoter region of PIN1 gene are associated with Alzheimer's disease
    Annoni, G
    Segat, L
    Arosio, B
    Galimberti, L
    Clerici, M
    Vergani, C
    Crovella, S
    [J]. GERONTOLOGIST, 2005, 45 : 600 - 601
  • [38] Association study of three polymorphisms of TGF-β1 gene with Alzheimer's disease
    Araria-Goumidi, L
    Lambert, JC
    Mann, DMA
    Lendon, C
    Frigard, B
    Iwatsubo, T
    Cottel, D
    Amouyel, P
    Chartier-Harlin, MC
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (01): : 62 - 64
  • [39] Effect of Proinflammatory Gene Polymorphisms on the Risk of Alzheimer's Disease
    Flex, Andrea
    Giovannini, Silvia
    Biscetti, Federico
    Liperoti, Rosa
    Spalletta, Gianfranco
    Straface, Giuseppe
    Landi, Francesco
    Angelini, Flavia
    Caltagirone, Carlo
    Ghirlanda, Giovanni
    Bernabei, Roberto
    [J]. NEURODEGENERATIVE DISEASES, 2014, 13 (04) : 230 - 236
  • [40] Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease
    Bullido, MJ
    Valdivieso, F
    [J]. MICROSCOPY RESEARCH AND TECHNIQUE, 2000, 50 (04) : 261 - 267
12345